Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | | 2.71M | $49.34M | - |
| CEO | ROBINS CHAD M | 2.58M | $47.06M | -124,998 |
| Other | | 1.23M | $22.44M | - |
| Other | ROBINS HARLAN S | 1.22M | $22.26M | -10,000 |
| COO | RUBINSTEIN JULIE | 607.7K | $11.07M | - |
Transactions
50 transactions · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2021-01-29 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 2,185 | $56.15 | $122,685.55 | -30.6% | → |
| 2021-01-29 | RUBINSTEIN JULIE | President | Sale+OE | 10,090 | $56.12 | $566,257.42 | -60.1% | → |
| 2021-01-29 | Cohen Chad M | Chief Financial Officer | Sale+OE | 100,000 | $56.13 | $5,612,600.92 | -55.3% | → |
| 2021-01-28 | RUBINSTEIN JULIE | President | Sale+OE | 30,000 | $57.39 | $1,721,580.18 | -56.6% | → |
| 2021-01-28 | ROBINS CHAD M | CEO and Chairman | Sell | 30,000 | $59.38 | $1,781,546.25 | -0.1% | → |
| 2021-01-27 | BALDO LANCE | Chief Medical Officer | Sale+OE | 40,000 | $58.95 | $2,358,117.38 | -56.5% | → |
| 2021-01-26 | Cohen Chad M | Chief Financial Officer | Sale+OE | 100,000 | $65.05 | $6,505,455.66 | -41.8% | → |
| 2021-01-26 | RUBINSTEIN JULIE | President | Sale+OE | 30,000 | $65.52 | $1,965,508.96 | -53.9% | → |
| 2021-01-22 | RUBINSTEIN JULIE | President | Sale+OE | 15,000 | $66.84 | $1,002,546.96 | -61.3% | → |
| 2021-01-21 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 17,329 | $66.90 | $1,159,310.10 | -86.2% | → |